Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

Assessments and reviews


Assessments

Completed assessments 2011-2015

Appraised by MSAC
MSAC IDTitle
1-2 April 2015
1182
The use of Intensity Modulated Radiation Therapy (IMRT) in the treatment of cancer
1-2 April 2015
1195
F-18 Flurodeoxyglucose Positron Emission Tomography (FDG PET) for the diagnosis of Alzheimer's Disease
1-2 April 2015
1234
Pathology tests for active mycobacterial infection
1-2 April 2015
1319
The use of Image Guided Radiation Therapy (IGRT) in the treatment of cancer
1-2 April 2015
1354
Intravascular ultrasound (IVUS) guided coronary stent insertion
1-2 April 2015
1361
Transcatheter Aortic Valve Implantation via Transfemoral or Transapical Delivery
1-2 April 2015
1365
Active middle ear implants for sensorineural hearing loss
1-2 April 2015
1377
Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
1-2 April 2015
1384
Bronchial thermoplasty for the treatment of severe persistent asthma
26-28 November 2014
1181
Non-mydriatic retinal photography (NMP) in persons with diabetes
26-28 November 2014
1196
Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression
26-28 November 2014
1197.1
Remote Monitoring of Patients with Implanted Cardiac Devices
26-28 November 2014
1243
The removal of imbedded corneal foreign bodies to any person presenting to an optometrist.
26-28 November 2014
1250.1
Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent). (Resubmission)
26-28 November 2014
1313
Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment
26-28 November 2014
1332
Second Opinion for Morphological/Interpretive Pathology
26-28 November 2014
1347
Transcatheter occlusion of the left atrial appendage for patients with non-valvular atrial fibrillation
26-28 November 2014
1360
Specialist dermatology services delivered by asynchronous store and forward technology
26-28 November 2014
1370
Ocriplasmin for symptomatic vitreomacular adhesion (sVMA) including macular hole
26-28 November 2014
1374
Insertion of subcutaneous electrode for the purpose of use with an implantable cardioverter defibrillator (ICD)
3 October 2014
1362.1
Resubmission Cetuximab and KRAS testing under MBS 73330
3 October 2014
1363
RAS (Kirsten RAS and Neuroblastoma RAS) mutation testing for eligibility for panitumumab treatment in previously untreated metastatic colorectal cancer patients
3 October 2014
1379
IncobotulinumtoxinA (XEOMIN), injection of, for blepharospasm, cervical dystonia (spasmodic torticollis) and post-stroke spasticity of the upper limb
3-4 April 2014
1098.1
Review of Interim Funded Service: Breast magnetic resonance imaging (MRI)
3-4 April 2014
1159
Palliative Care consultation Items
3-4 April 2014
1170
Intensive Care Medicine consultation Items
3-4 April 2014
1190
MRI for small bowel and pelvis in Crohn disease
3-4 April 2014
1192.1
The reduction of mitral regurgitation through tissue approximation using transvenous/transeptal techniques (resubmission)
3-4 April 2014
1197
Remote monitoring of patients with implanted cardiac devices
3-4 April 2014
1203
Catheter-free ambulatory pH test for gastroesophageal reflux disease (GERD)
3-4 April 2014
1267
HBA1c test for the diagnosis of diabetes mellitus
3-4 April 2014
1268
Radium 223 for the treatment of patients with symptomatic castrate resistant prostate cancer with skeletal metastases
3-4 April 2014
1276
National Cervical Screening Program
3-4 April 2014
1342.1
Oncotype DX breast cancer assay to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit (Resubmission)
3-4 April 2014
ref43
Cone Beam Computerised Tomography (CBCT) for various for dental/craniofacial imaging purposes
28 November 2013
1146.1
Capsule Endoscopy for the Diagnosis of Suspected Small Bowel Crohn Disease (Resubmission)
28 November 2013
1206
Single balloon enteroscopy system for obscure GI bleeding (small bowel)
28 November 2013
1223
Insertion, replacement, or removal of a cardiac resynchronisation therapy device capable of defibrillation (CRT-D) for mild, moderate or severe chronic heart failure (NYHA II, III or IV)
28 November 2013
1250
Testing of the ALK gene in tumour material from patients with non-small cell lung cancer to determine eligibility for treatment with crizotinib
28 November 2013
1272
Transurethral injection of botulinum toxin (Botox) into the bladder wall for urinary incontinence due to idiopathic overactive bladder
28 November 2013
1342
Gene expression profiling of 21 genes in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit
1 August 2013
1147
Implantation of Fiducial Markers into Prostate Gland or Prostatic Surgical Bed for Radiotherapy
1 August 2013
1152
Genetic Testing for Hereditary Mutations in the RET Gene
1 August 2013
1167
Addiction medicine consultation Items
1 August 2013
1171
Sexual Health Medicine consultation Items
1 August 2013
1273
Matrix-induced Autologous Chondrocyte Implant
1 August 2013
1293
EGFR testing in Patients with Locally Advanced or Metastatic Non Small-Cell Lung Cancer to determine eligibility for afatinib
1 August 2013
1310
Optical Coherence Tomography, for the diagnosis and monitoring of treatment effectiveness with aflibercept in patients with central retinal vein occlusion
1 August 2013
1330
Transcatheter closure of patent ductus arteriosus
1 August 2013
1346
Revision of 11820 (re-submission)
5 April 2013
1157
Liquid Based Cytology (LBC)
5 April 2013
1207
Diagnostic testing to determine the presence of V600 mutations in patients with locally advanced or metastatic melanoma
5 April 2013
1350
Ranibizumab for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO)
29-30 November 2012
1158
Robotic image-guided stereotactic precise beam radiosurgery and radiotherapy
29-30 November 2012
1149
Holmium YAG Laser enucleation of the prostate (HoLEP) for the treatment of benign prostatic hyperplasia
29-30 November 2012
1174
Pathology test to detect CCR5 tropic HIV for maraviroc
29-30 November 2012
1192
Percutaneous reconstruction of an insufficient mitral valve through tissue approximation using transvenous/trans-septal techniques
29-30 November 2012
1334
Subcutaneous Immunoglobulins (SCIg)
29-30 November 2012 &
5 April 2013
1221
Transurethral injection of botulinum toxin (BOTOX) into the bladder wall for urinary incontinence due to neurogenic detrusor overactivite
29-30 November 2012
1150
Insertion of Colonic stents
29-30 November 2012
1163
Testing for HER2 status in Gastric Cancer for access to trastuzumab
29-30 November 2012
1168
Injection of botulinum toxin (BOTOX) for prophylaxis of headaches in adults with chronic migraine
29-30 November 2012
1161
Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC)
2 August 2012
1166
Radiofrequency ablation (RFA) for the treatment of varicose veins due to chronic venous insufficiency
2 August 2012 &
5 April 2013
1172
BRAF mutation test for treatment of metastatic melanoma for access to vemurafenib
2 August 2012
1173
EGFR mutation test for treatment of locally advanced (stage IIIB) or metastatic (stage IV) NSCLC for access to erlotinib
2 August 2012
1230
Testing for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab
2 August 2012
Reference 2
Positron emission tomography (PET)
29 March 2012
1299
Proposed Amendment to Transperineal Ultrasound Prostate Biopsy (MBS Item 37219)
29 March 2012
1300
Removal of Gynaecomastia from the Liposuction Component in Barraquers-Simon’s Syndrome (MBS Item 45585)
Review
1178r2
Review of MBS items for specific ophthalmology services under the MBS Quality Framework Stage II
Review
1178r
Review of MBS items for specific ophthalmology services under the MBS Quality Framework Stage 1
29 March 2012
1144
Pathology Tests for Latent Mycobacterial Infection
29 March 2012
1156
Diagnostic use of thyrotropin alfa-rch for Patients with Well-Differentiated Thyroid Cancer
-
1054
Hyperbaric oxygen therapy
29 March 2012
1054.1
Review of Interim Funded Service: Hyperbaric Oxygen Therapy (HBOT) for the Treatment of Chronic Non-Diabetic Wounds and Non-Neurological Soft Tissue Radiation Injuries
29 November 2011
1176
Assessment of Application for Joint injections
29 November 2011
1153
Genetic Testing for Hereditary Mutation of the von Hippel-Lindau (VHL) Gene
29 November 2011
1145
Artificial Intervertebral Disc Replacement in Patients with Cervical Degenerative Disc Disease
29 November 2011
1139
Measurement and Determination of Procalcitonin (PCT)
27 July 2011
1146
Capsule Endoscopy for the Diagnosis of Suspected Small Bowel Crohn's Disease
27 - 28 April 2011
1090.1
Review of Interim Funded Service: Artificial Intervertebral Disc Replacement - Lumbar
27 - 28 April 2011
27.1
Review of Kyphoplasty for the Treatment of Vertebral Compression Fracture and Review of Interim Funded Service: Vertebroplasty for the Treatment of Vertebral Compression Fracture
Top of page

Completed assessments 1998-2010

For MSAC Applications 1001 - 1143 please go to Historical resources - past publications.

Reassigned - applications have been referred to another area within the department

MSAC ID
Title
1390
Epicutaneous Patch Testing
1359
Perioperative Nurse Surgical Assistants (PNSA) to gain eligibility as providers of services that attract a Medicare Benefit Schedule (MBS) rebate for eligible surgical assisting services provided during surgery or procedures.

Withdrawn

MSAC ID
Title
1355
Review of Medicare funded finger fracture services
1318
KRAS mutation testing for access to panitumumab
1309
Pain Medicine Professional Attendance Items
1233
Out of hours emergency coronary angiography and/or coronary angioplasty and stenting
1205a
Review of Medicare–funded Wrist Surgery services
1175
In situ hybridization (ISH) diagnostic testing to determine HER-2 status in patients with advanced or metastatic breast cancer (stage IIIA-IV) to inform eligibility to lapatinib
1169
Sports and Exercise medicine consultation Items
1160
Changes to Hepatitis C testing regime for access to telaprevir
1154
Non-invasive assessment of artificial stiffness by applanation tonometry for titration of anti-hypertensive medication in CKD
Top of page

Reviews

Current reviews

The outcomes of the following reviews are likely to be considered by the MBS Review Taskforce:

Completed reviews 2010-2015

Top of page

References

For MSAC References 1 - 44 please go to Historical Resources Past Publications

Nationally Funded Centres

Nationally Funded Centres
Reference 36 a-e

Horizon scanning

Horizon scanning assessments of emerging health technologies represent a snap-shot in time, and as such, the information contained in the reports should be used with due caution. For further information relating to Horizon Scanning please visit the website.

Page currency, Latest update: 02 March, 2016